First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.6036 USD Market Closed
Updated: May 17, 2024

Atara Biotherapeutics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atara Biotherapeutics Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Atara Biotherapeutics Inc
NASDAQ:ATRA
Other Liabilities
$47.3m
CAGR 3-Years
1%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.3B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
25%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$25.8B
CAGR 3-Years
59%
CAGR 5-Years
29%
CAGR 10-Years
52%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
24%
CAGR 5-Years
62%
CAGR 10-Years
32%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is Atara Biotherapeutics Inc's Other Liabilities?
Other Liabilities
47.3m USD

Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Other Liabilities amounts to 47.3m USD.

What is Atara Biotherapeutics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
25%

Over the last year, the Other Liabilities growth was -72%. The average annual Other Liabilities growth rates for Atara Biotherapeutics Inc have been 1% over the past three years , 25% over the past five years .